Edition:
United States

Imv Inc (IMV.TO)

IMV.TO on Toronto Stock Exchange

7.31CAD
18 Dec 2018
Change (% chg)

-- (--)
Prev Close
$7.31
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
37,632
52-wk High
$9.49
52-wk Low
$5.18

Chart for

About

Imv Inc, formerly known as Immunovaccine Inc is a Canada-based clinical-stage immuno oncology company. The Company develops products based on its vaccine enhancement platform with a primary focus on T lymphocytes (T cell) activating therapies for cancer. The Company's DepoVax adjuvanting/delivery platform produces immune... (more)

Overall

Beta: 1.51
Market Cap(Mil.): $139.19
Shares Outstanding(Mil.): 127.70
Dividend: --
Yield (%): --

Financials

  IMV.TO Industry Sector
P/E (TTM): -- 69.72 34.40
EPS (TTM): -0.09 -- --
ROI: -73.34 9.00 14.96
ROE: -125.02 10.14 16.53

Earnings vs. Estimates